Boise Cascade Company logo

Boise Cascade Company (BC0)

Market Closed
3 Jun, 06:08
XSTU XSTU
73. 98
-0.1
-0.13%
- Market Cap
- P/E Ratio
0.84% Div Yield
0 Volume
- Eps
74.08
Previous Close
Day Range
73.98 73.98
Year Range
73.98 144.95

Summary

BC0 closed today lower at €73.98, a decrease of 0.13% from yesterday's close, completing a monthly decrease of -9.16% or €7.46. Over the past 12 months, BC0 stock lost -35.36%.
BC0 pays dividends to its shareholders, with the most recent payment made on Mar 19, 2025. The next announced payment will be in In 2 weeks on Jun 18, 2025 for a total of €0.21.
The last earnings report, released on May 05, 2025, missed the consensus estimates by -0.23%. On average, the company has fell short of earnings expectations by -0.07%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track BC0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BC0 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
New Strong Sell Stocks for May 28th

New Strong Sell Stocks for May 28th

BCC, DOOO and CMT have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2025.

Zacks | 6 days ago
Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval from the UAE DOH to commence Phase 2 clinical study (SKNJCT-004) to non-invasively treat BCC of the skin.

Newsfilecorp | 1 week ago
Boise Cascade Company (BCC) Q1 2025 Earnings Call Transcript

Boise Cascade Company (BCC) Q1 2025 Earnings Call Transcript

Boise Cascade Company (NYSE:BCC ) Q1 2025 Earnings Conference Call May 6, 2025 9:30 AM ET Company Participants Chris Forrey - VP, Finance & IR Nathan Jorgensen - CEO & Director Kelly Hibbs - SVP, CFO, Principal Financial & Accounting Officer and Treasurer Jeff Strom - COO Joanna Barney - EVP, Building Materials Distribution Conference Call Participants Susan Maklari - Goldman Sachs Kurt Yinger - D.A. Davidson George Staphos - Bank of America Securities Zack Pacheco - Loop Capital Markets Ketan Mamtora - BMO Capital Markets Reuben Garner - Benchmark Operator Good morning.

Seekingalpha | 4 weeks ago

Boise Cascade Company Dividends

Boise Cascade Company logo
BC0 31 Aug 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 14 Jul 2021
Other
€2 Per Share
Boise Cascade Company logo
BC0 28 May 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 19 Feb 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 30 Nov 2020
Other
€0.1 Per Share

Boise Cascade Company Earnings

5 May 2025 Date
1.28
Cons. EPS
1.06
EPS
18 Feb 2025 Date
1.78
Cons. EPS
1.78
EPS
4 Nov 2024 Date
2.32
Cons. EPS
2.33
EPS
28 Oct 2024 Date
-
Cons. EPS
-
EPS
5 Aug 2024 Date
2.68
Cons. EPS
2.84
EPS
Boise Cascade Company logo
BC0 31 Aug 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 14 Jul 2021
Other
€2 Per Share
Boise Cascade Company logo
BC0 28 May 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 19 Feb 2021
Other
€0.1 Per Share
Boise Cascade Company logo
BC0 30 Nov 2020
Other
€0.1 Per Share
5 May 2025 Date
1.28
Cons. EPS
1.06
EPS
18 Feb 2025 Date
1.78
Cons. EPS
1.78
EPS
4 Nov 2024 Date
2.32
Cons. EPS
2.33
EPS
28 Oct 2024 Date
-
Cons. EPS
-
EPS
5 Aug 2024 Date
2.68
Cons. EPS
2.84
EPS

Boise Cascade Company (BC0) FAQ

What is the stock price today?

The current price is €73.98.

On which exchange is it traded?

Boise Cascade Company is listed on NYSE.

What is its stock symbol?

The ticker symbol is BC0.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Boise Cascade Company ever had a stock split?

No, there has never been a stock split.

Boise Cascade Company Profile

Construction Materials Industry
Basic Materials Sector
Mr. Nathan R. Jorgensen CEO
XSTU Exchange
US09739D1000 ISIN
US Country
7,670 Employees
2 Jun 2025 Last Dividend
- Last Split
- IPO Date

Overview

Boise Cascade Company, headquartered in Boise, Idaho, is a leading manufacturer of wood products and distributor of building materials in the United States and Canada. Founded in 2004, the company operates through two primary segments: Wood Products and Building Materials Distribution. Boise Cascade is dedicated to serving a wide range of customers, including dealers, home improvement centers, wholesalers, specialty distributors, and industrial converters. Its diverse product offerings cater to the construction of new residential housing, the repair-and-remodeling of existing housing, light industrial and commercial building constructions, as well as various industrial applications.

Products and Services

  • Laminated Veneer Lumber and Laminated Beams

    Manufactured for use in headers and beams, Boise Cascade’s laminated veneer lumber and laminated beams are integral for structural support in residential and commercial constructions.

  • I-joists

    These are engineered for residential and commercial flooring and roofing systems, as well as other structural applications, providing a high-strength, lightweight solution for building needs.

  • Structural, Appearance, and Industrial Plywood Panels

    Boise Cascade offers plywood panels in various grades for structural integrity, aesthetic applications, and industrial use, accommodating a wide range of construction necessities.

  • Ponderosa Pine Shop Lumber and Appearance Grade Boards

    The company produces ponderosa pine shop lumber and boards, prized for their appearance and quality, suitable for a variety of projects including high-quality finishes.

  • Oriented Strand Boards, Plywood, and Lumber

    Through its Building Materials Distribution segment, Boise Cascade distributes essential building materials such as oriented strand boards, plywood, and lumber to meet comprehensive construction requirements.

  • General Line Items

    Including siding, composite decking, doors, metal products, insulation, and roofing, these general line items are distributed to support a wide array of building and construction projects.

  • Engineered Wood Products

    Boise Cascade markets and sells engineered wood products that offer superior performance and environmental benefits for use in various construction applications, from residential to commercial buildings.

Contact Information

Address: 1111 West Jefferson Street
Phone: 208-384-6161